Titre:
  • Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection
Auteur:Lacaze-Masmonteil, Thierry; Seidenberg, Juergen; Mitchell, Ian; Cossey, Veerle; Cihar, Martin; Csader, Michal; Baarsma, Rienk; Valido, Marques; Pollack, Paul P.F.; Groothuis, Jessie J.R.; Allegaert, Karel; Lombet, Jacques; Haumont, Dominique; Plaskie, Katleen; Davies, Dele Dele H.D.; Sauve, Reg R.S.; Langley, Joanne J.M.; Liska, Karel; Andre, Patrick; Lequien, Pierre; Kacet, Nadine; Lapeyre, Fabrice; Wickenburg-Ennen, Barbara; Nolte, Helga; Harding, Peter Andreas; Ramos, Sandra; Carolino, Margarida; Marques, Antónia
Informations sur la publication:Drug safety, 26, 4, page (283-291)
Statut de publication:Publié, 2003
Sujet CREF:Pharmacologie
Toxicologie pharmaceutique
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0114-5916
info:doi/10.2165/00002018-200326040-00005
info:scp/0037232387
info:pmid/12608889